CQC guidance for CBPM providers
The Care Quality Commission (CQC) has recently released a report called ‘The safer management of controlled drugs: annual update 2023‘.
In a section entitled ‘Administration of CBPMs in health and social care settings’, the CQC have advised that providers (e.g. clinics, pharmacies) should consider the following in their policies and processes:
- ensuring the product has been prescribed
- how to support patients with ongoing supplies, if required
- safe storage, records and appropriate authorised access, as with other Schedule 2 controlled drugs
- appropriate training for staff if they are required to support with administration
- the position on vaping, and the possible need to obtain prescribed alternatives where people are not able to vape
- whether a risk assessment is required
